Qianjing Rehabilitation, formerly Changzhou Qianjing Rehabilitation Equipment Co., Ltd. established in 1996, has focused on the rehabilitation industry for over 20 years and completed its shareholding system reform in June 2015. Adhering to the values of "Caring for Life and Creating Welfare," the company is committed to its mission of "popularizing professional rehabilitation concepts, meeting the rehabilitation needs of the public, improving the quality of life for those in need, and utilizing societal resources more effectively." It now boasts a comprehensive and high-quality product system covering various branches, including PT (Physical Therapy), OT (Occupational Therapy), ST (Speech Therapy), R-aT (Robot-Assisted Therapy), special education equipment, and rehabilitation assistive devices. The company's products and services extend to over 20,000 terminal institutions in key areas such as national healthcare, civil welfare and elderly care, special education, and disability rehabilitation, enjoying high recognition and a significant scale advantage in the industry.

Artificial Intelligence + Medical Rehabilitation       The maturation and popularization of artificial intelligence technology will put the medical industry on a technology-driven track, evolving from experience-based medicine to evidence-based medicine (statistics + small sample data) and further to personalized diagnosis and treatment based on big data and artificial intelligence. The medical industry will undergo fundamental changes. From the patient's perspective, personalized diagnosis and treatment will undoubtedly greatly improve the accuracy and targeting of treatment plans; from the doctor's perspective, the advent of AI doctors will fundamentally solve the problem of medical resource shortages.

With social progress and the awakening of people's health awareness, and the continuous intensification of the aging population, the demand for improving medical technology, extending human life, and enhancing health is becoming more urgent. In the actual development of the industry, China's intelligent medical care is still in its infancy. In the future, our company will increase investment in the development and investment of basic aspects such as databases, algorithms, and general technologies, and further expand the application fields of intelligent medical care while consolidating the foundation.

China-UK Joint Research Institute for Artificial Intelligence Learning:       Jointly established by more than 10 professors and doctors who have returned from studying abroad from the University of Ulster in the UK, THE SMART CLOUD ZONE LTD., Fujian Normal University, and Zhiliang Zhichuang Technology Co., Ltd. The research institute's team members include Minjiang Scholars, Xiamen Double Hundred Plan talents, high-level talents introduced by Fujian Province, and researchers from world-class institutions such as Imperial College London. Team members have long been engaged in the application research of artificial intelligence, leading more than 30 national and EU projects. The institute focuses on researching deep learning and other artificial intelligence algorithms, developing FPGA-based physiological signal perception chips, artificial intelligence EEG feature extraction methods, and artificial intelligence learning statistical analysis algorithms.